anonymous
Guest
anonymous
Guest
Now that BNJ is gone we all realize on the sales team there is no hope, right? TC, CH, JS all gone and there is no one left to give it to us straight or dig us out of this hole. Why all the cost cutting and focus on revenue per specimen? Hmm.. maybe because our company has a $600 million loan they will NEVER pay off. Right now, we pay $45 million per year just in interest. In 4 years, the principle has to be paid in a balloon payment. Do you think the "board" is more concerned about raising commissions or paying down the debt? If there is no new product on the horizon, it's Chapter 11 (or 7) time in 2017. Polish your resumes.